This study aimed to correlate the multidrug resistance (MDR) and sequence type (ST) clones of community-associated (CA) meticillin-resistant Staphylococcus aureus (MRSA) to identify the genes responsible for clindamycin and mupirocin resistance in S. aureus isolates from paediatric hospitals in mainland China. A total of 435 S. aureus isolates were collected. Compared with CA meticillinsusceptible S. aureus (MSSA), the resistance rates of CA-MRSA to ciprofloxacin, chloramphenicol, gentamicin and tetracycline were higher (19.0 vs 2.6 %, P,0.001; 14.7 vs 3.1 %, P,0.001; 14.7 vs 3.1 %, P,0.01; and 46.0 vs 13.3 %, P,0.001, respectively). Compared with hospital-associated (HA)-MRSA, the resistance rates of CA-MRSA to ciprofloxacin, gentamicin, rifampicin, tetracycline and trimethoprim-sulfamethoxazole were lower (19 vs 94.8 %, P,0.001; 14.7 vs 84.4 %, P,0.001; 5.5 vs 88.3 %, P,0.001; 46 vs 94.8 %, P,0.001; and 1.8 vs 9.1 %, P,0.01, respectively). The resistance rates of CA-MRSA, HA-MRSA and CA-MSSA to clindamycin (92.0, 77.9 and 64.1 %, respectively) and erythromycin (85.9, 77.9 and 63.1 %, respectively) were high. The MDR rates (resistance to three or more non-b-lactams) were 49.6, 100 and 14 % in the CA-MRSA, HA-MRSA and CA-MSSA isolates, respectively. Five of seven ST clones in the CA-MRSA isolates, namely ST59, ST338, ST45, ST910 and ST965, had MDR rates of .50 % (67.9, 87.5, 100, 50 and 83.3 %, respectively). The constitutive phenotype of macrolide-lincosamide-streptogramin B (MLS B ) resistance (69 %) and the ermB gene (38.1 %) predominated among the MLS B -resistant CA S. aureus strains. The resistance rate to mupirocin was 2.3 % and plasmids carrying the mupA gene varied in size between 23 and 54.2 kb in six strains with high-level resistance as determined by Southern blot analysis. The present study showed that resistance to non-b-lactams, especially to clindamycin, is high in CA-MRSA isolates from Chinese children and that the profile of resistance is related to clonal type. This study revealed distinctive patterns of MLS B -resistant genes among CA S. aureus isolates.
INTRODUCTION
Meticillin-resistant Staphylococcus aureus (MRSA) is an important pathogen that causes healthcare-and communityassociated (CA) infections worldwide (Grundmann et al., 2006) . As a typical pathogen with multidrug-resistance (MDR), hospital-associated (HA) MRSA is well known. Recently, an increasing number of studies have shown that CA-MRSA isolates from certain areas have become resistant to multiple drugs, which has enabled them to invade hospitals and affect the distribution of MRSA clones (David et al., 2006) . Clindamycin and muprocin are the preferred drugs for the treatment of both meticillin-sensitive S. aureus (MSSA) and CA-MRSA infections in children, particularly for skin and soft-tissue infections (SSTIs) (Liu et al., 2011) . However, the increasing resistance limits the effectiveness of these drugs.
For adults, the prevalence rates of MRSA vary. A study in Taiwan revealed that~17.3 % of all S. aureus isolates were MRSA , whilst the rate was nearly 50 % in the USA (Waites et al., 2006) and China (Wang et al., 2008) . A study in Texas reported that 21 % of S. aureus isolates from children were MRSA, and CA-MRSA accounted for 12 % (Whitby et al., 2011) . For Chinese children, this value was only 1 % for CA-MRSA . In our previous study, CA-MRSA isolates were found to be associated largely with the sequence type (ST) 59 MRSA-IV clone, mostly causing SSTIs. Some isolates have acquired resistance to a variety of drugs (Geng et al., 2010a) . However, the non-b-lactam resistance of S. aureus in Chinese children and the MDR of different ST clones of CA-MRSA have not been analysed and the prevalence of certain resistance genes also has not been reported. The current study aimed to determine the non-b-lactam resistance of S. aureus isolates, the MDR of different clones of CA-MRSA and the genes responsible for the resistance to clindamycin and mupirocin of S. aureus isolates in Chinese children.
METHODS
Bacterial strains. The current study involved eight regional hospitals, namely Beijing Children's Hospital, the Paediatric Hospital of Fudan University, Guangzhou Children's Hospital, Shenzhen Children's Hospital, Chongqing Children's Hospital, the Affiliated Hospital of Wenzhou Medical College, Shenyang Shengjing Hospital and Guangzhou Maternal and Child Health Hospital, located in seven cities throughout China (Fig. 1) . To avoid over-representation, we included only the first isolate from each patient. During the study period, there was no MRSA infection outbreak. According to the criteria of Klevens et al. (2007) , we collected 163 CA-MRSA isolates from children aged 0-14 years between July 2008 and May 2010. There were 77 HA-MRSA and 195 MSSA isolates collected at the same time from the same place to match the CA-MRSA isolates and the data were compared. Collection, transportation and identification of the samples were performed as described previously (Geng et al., 2010b) .
Multilocus sequence typing (MLST). MLST was performed on the 163 CA-MRSA isolates (Enright et al., 2000) . Seven housekeeping gene sequences were compared with known alleles from the MLST database (http://saureus.mlst.net), and allelic profiles were determined based on the database.
Antimicrobial susceptibility testing. All S. aureus isolates from participating centres were identified again using a Staphaurex Plus kit (Murex Diagnostics) at the central laboratory. The MICs of penicillin, cefoxitin, cefuroxime, erythromycin, clindamycin, ciprofloxacin, chloramphenicol, gentamicin, rifampicin, tetracycline, trimethoprim-sulfamethoxazole, vancomycin, linezolid (all from Sigma) and mupirocin (National Institute for the Control of Pharmaceutical and Biological Products) were determined by a broth microdilution method in accordance with the guidelines of the Clinical and Laboratory Standards Institutes (CLSI, 2010) . Fusidic acid and tigecycline MICs were determined according to European Committee on Antimicrobial Susceptibility Testing (EUCAST, version 1.3, 2010) guidelines. Isolates with an MIC of 8-256 mg l 21 were regarded as low-level mupirocin resistant; and those with an MIC of ¢512 mg l 21 were regarded as high-level mupirocin resistant. S. aureus ATCC 29213 was used as the control in all tests. Inducible clindamycin resistance was detected using a disc approximation D-zone test. The MIC 90 of ceftobiprole was determined for MRSA isolates. Isolates were classified as having MDR if they were resistant to three or more different classes of nonb-lactams based on their susceptibility to gentamicin, erythromycin, clindamycin, ciprofloxacin, chloramphenicol, rifampicin, tetracycline and trimethoprim-sulfamethoxazole (David et al., 2006) and five other non-b-lactams, namely vancomycin, fusidic acid, tigecycline, mupirocin and linezolid.
Phenotypic-inducible resistance to clindamycin by the D-test.
In staphylococci, resistance to macrolide-lincosamide-streptogramin B (MLS B phenotype) antibiotics is caused by the erm genes. Expression of resistance to clindamycin can be either inducible (iMLS B ) or constitutive (cMLS B ). The iMLS B phenotype was determined for S. aureus isolates that were clindamycin resistant and erythromycin sensitive using the D-zone test, as described previously (Yoon et al., 2008) . All 435 strains were tested by a disc diffusion method. An aqueous suspension of bacterial growth was adjusted to an OD 600 of 0.5 and inoculated by swabbing (25 ml per plate) on Mueller-Hinton agar (Oxoid). Clindamycin (2 mg) and erythromycin (15 mg) disks were placed in the centre of the plate separated by a distance of 1.5 cm between the edges. The plates were incubated at 37 uC for 24 h. Inducible resistance to clindamycin was defined as blunting of the clear circular area of no growth around the clindamycin disk on the side adjacent to the On: Wed, 17 Jul 2019 16:33:11 erythromycin disk and was designated D-zone-test-positive. The absence of a blunted zone of inhibition was designated D-zonetest-negative, indicating that the strain was truly susceptible to clindamycin.
Detection and sequencing of MLS B resistance genes. DNA was isolated using a DNA extraction kit (TaKaRa) according to the manufacturer's instructions. DNA was used as template in all PCRs described below. Isolates resistant to erythromycin or clindamycin were tested by PCR using specific primers to detect the presence of the ermA, ermB, ermC, msrA, msrB and linA genes, as described by Sutcliffe et al. (1996) .
Locating the muprocin resistance gene by PFGE and Southern blot analysis. High-level mupirocin-resistant S. aureus isolates were detected using primers mupA-F (59-TATATTATGCGATGGAAG-GTTGG-39) and mupA-R (59-AATAAAATCAGCTGGAAAGTGT TG-39) amplifying the mupA gene (Liu et al., 2010) . The mupA gene amplicon of each isolate was sequenced and compared with sequences available in BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi). The nucleotide sequences and deduced amino acid sequences were analysed using the Lasergene software package (DNASTAR). A modification of the PFGE protocol described by Goering and Winters (1992) was used (Bannerman et al., 1995) . The plugs were transferred to 3 ml fresh TE buffer for storage at 4 uC. Before electrophoresis, the plug was cut into small slices (265 mm) without lysis by SmaI to detect plasmids in the S. aureus isolates. Electrophoresis was performed with a CHEF-Mapper electrophoresis cell (Bio-Rad) on a 1 % agarose gel. l HindIII-digested DNA (New England Biolabs) and plasmids of Escherichia coli V517 were used as size standards and served as controls for the running parameters of the CHEF-Mapper units. The running parameters were as follows: autostage 10-150 kb, 6 V cm 21 , running time 6 h and temperature 12-14 uC. The gels were stained with ethidium bromide and photographed. The plasmids were then transferred to a positively charged nylon membrane (Roche Applied Science), which was probed by a 458 bp PCR-amplified mupA gene probe using a DIG High Prime DNA Labelling and Detection kit II (Roche Applied Science).
Statistical analysis. All derived data were analysed using WHONET 5.4 software. Categorical variables were compared by a x 2 or twotailed Fisher's exact test. Statistical analysis was carried out using SPSS 13.0 software and the level of significance was set as P50.05.
RESULTS

Antimicrobial resistance to non-b-lactam agents of S. aureus
The antimicrobial resistance rates of 240 (163 CA-MRSA and 77 HA-MRSA) isolates of MRSA and 195 CA-MSSA isolates were analysed (Table 1) . Compared with CA-MSSA, the resistance rates of CA-MRSA to ciprofloxacin, chloramphenicol, gentamicin and tetracycline were higher (19.0 vs 2.6 %, P,0.001; 14.7 vs 3.1 %, P,0.001; 14.7 vs 3.1 %, P,0.01; and 46.0 vs 13.3 %, P,0.001, respectively). Compared with HA-MRSA, the resistance rates of CA-MRSA to ciprofloxacin, gentamicin, tetracycline and trimethoprim-sulfamethoxazole were lower (19 vs 94.8 %, P,0.001; 14.7 vs 84.4 %, P,0.001; 5.5 vs 88.3 %, P,0.001; 46 vs 94.8 %, P,0.001; and 1.8 vs 9.1 %, P,0.01, respectively). The resistance rates of CA-MRSA, HA-MRSA and CA-MSSA to clindamycin and erythromycin were high (92.0, 77.9 and 64.1 %, and 85.9, 77.9 and 63.1 %, respectively). All isolates were susceptible to linezolid, tigecycline and vancomycin. One CA-MRSA, one HA-MRSA and two CA-MSSA isolates were fusidic acid resistant. Nine CA-MRSA and one HA-MRSA isolates were resistant to mupirocin. Four isolates exhibited lowlevel resistance to mupirocin and six isolates showed highlevel resistance to mupirocin.
MDR and resistance phenotypes of S. aureus isolates
The MDR and resistance phenotypes of the three groups were analysed ( Table 2 ). The MDR rates were 49.6, 100 and 14 % in CA-MRSA, HA-MRSA and CA-MSSA isolates, respectively (P,0.001). The most prevalent resistance phenotype of HA-MRSA isolates was gentamicin-tetracyline-rifampicin-ciprofloxacin (34.3 %), and the top three phenotypes accounted for 54.3 %. Compared with HA-MRSA, the resistance phenotypes of CA-MRSA and CA-MSSA varied. The most prevalent resistance pattern of CA-MRSA was erythromycin-clindamycin-tetracycline (8.7 %).
Antimicrobial resistance and MDR related to ST clones in CA-MRSA isolates
The 163 CA-MRSA isolates could be divided into 14 MLST clones (ST1, ST7, ST45, ST59, ST88, ST217, ST239, ST338, ST398, ST509, ST910, ST965, ST1349 and ST1409). There were seven ST clones containing four or more isolates, with a total of 145 isolates (Table 3) . Most isolates showed high resistance to clindamycin and erythromycin. Five ST clones had .50 % MDR rates. ST59 was resistant to tetracycline (57.1 %) with an MDR rate of 67.9 %. ST338 was resistant to chloramphenicol (75 %) and tetracycline (87.5 %) with an MDR rate of 87.5 %. All ST45 isolates were resistant to erythromycin, clindamycin, gentamicin, tetracycline and ciprofloxacin with the rate of MDR reaching 100 %. ST910 and ST965 also showed MDR (50 and 83.3 %, respectively). ST1 and ST88 showed less MDR (36.4 and 16.7 %, respectively). Isolates resistant to mupirocin belonged to the ST59, ST910 and ST1 clones.
Resistance genotypes and genes among MLS B -resistant S. aureus isolates
Among the MLS B -resistant S. aureus strains, the cMLS B phenotype accounted for 69 %, whilst the iMLS B phenotype accounted for 31 %. Two isolates showed a foggy D-shaped inhibitory zone (fMLS B ). The resistance genes of ermA, ermB and ermC were detected in 16, 26.3 and 42.5 %, respectively, of the MLS B -resistant S. aureus strains. Three isolates carried the msrA gene, the msrB gene was not found and 15 strains contained the linA gene. Approximately 73.9 % of CA-MRSA isolates were of the cMLS B phenotype and mainly carried ermB (54 %), and a similar situation was observed for CA-MSSA ( Detection and location of the mupirocin resistance gene
The mupA gene was not detected in low-level mupirocinresistant isolates, whereas the high-level mupirocin-resistant isolates with MICs of 512 mg l 21 tested positive for the mupA gene. Southern blot analysis showed that the mupA gene probe only hybridized with plasmids between 23 and 54.2 kb (Fig. 2) .
DISSCUSSION
Traditionally, CA-MRSA strains are characterized by susceptibility to most non-b-lactams, as reported by studies in northern Europe (Otter & French, 2010) and elsewhere, with early American reports (Herold et al., 1998) . Since 2003, researchers from the USA, Taiwan and other countries have shown the increasing non-b-lactam resistance of CA-MRSA isolates. In the USA, the resistance rates were determined as 3-24 % for clindamycin (Hultén et al., 2006) , 3-24 % for tetracyclines (Ruhe & Menon, 2007) and 0-10 % for cotrimoxazole (Fridkin et al., 2005) . CA-MRSA isolates from the current study yielded similar results except for clindamycin (92 vs 3-24 %) and tetracycline (46 vs 3-24 %). Surveillance performed by the Asian Network for Surveillance of Resistant Pathogens group presented a more serious resistance to non-b-lactams of CA-MRSA collected mostly from adults (Song et al., 2011) . The results may be due to the varying pressures of antibiotics in different areas and populations.
In 2011, the guidelines released by the Infectious Diseases Society of America indicated clindamycin as an important drug choice against CA-MRSA strains, especially in the treatment of SSTIs (Liu et al., 2011) . In Europe, clindamycin is also recommended as the only treatment for SSTIs (De Angelis et al., 2011) . The results of the current study showed that clindamycin resistance in CA-MRSA strains was high (92 %). The resistant rate of MSSA reached as high as 64.1 %, indicating that it may not be suitable for Chinese children with S. aureus infection. Ciprofloxacin susceptibility is usually used as a marker of CA-MRSA (Otter & French, 2008 ). In the current study, the ciprofloxacin resistant rate was 19 %. In 2006, the US Centers for Disease Control and Prevention produced a definition of hospital-associated multidrugresistant organisms, defining MRSA as multidrug-resistant organisms even if they are resistant to only one class of antimicrobial agent (David et al., 2006) . However, to date there is no guideline on the MDR of CA-MRSA, and MDR is mostly defined as resistance to three or more non-b-lactams.
In the USA, 17-19.0 % of CA-MRSA strains obtained from San Francisco were found to be multidrug resistant (Pan et al., 2003; Carleton et al., 2004) . In Taiwan, a higher MDR rate of CA-MRSA (82 %), close to that of HA-MRSA (90 %), was reported (Chen et al., 2009) . The MDR rate of CA-MRSA in the current study was 49.6 % and the phenotypes of MDR were variable. The carriage of resistant genotypes or their expression may have been different and they seemed to have been derived from more diverse S. aureus populations than the HA-MRSA strains.
The present study is the first report on non-b-lactam resistance of different CA-MRSA clones isolated from Chinese children. Five out of seven ST types of CA-MRSA had a .50 % MDR rate. The rate of MDR in ST59 has been reported to be ,1 % in the USA (Pan et al., 2003) and 46 % in Taiwan (Chen et al., 2009) . Compared with these reports, the ST59 clone in the current study expressed a higher MDR rate (67.9 %). Seven of the eight isolates of ST338 showed resistance to more than three non-b-lactams in this study. In addition, 75 % of the isolates of ST910, which is found only in China, were resistant to five non-blactams. All ST45 isolates were resistant to erythromycin, clindamycin, gentamicin, tetracycline and ciprofloxacin.
Recently, Chen et al. (2009) in Taiwan showed that CA-MRSA with an ST59 background quickly adapted to the hospital environment without major evolution. In the USA and Taiwan,~60 % mortality was caused by ST45 strains, and the multiresistant characteristic of these clones may be one of unique virulence (Moore et al., 2010) .
In the current study, the high-level mupirocin resistance mupA gene was located on a plasmid varying in size between 23 and 54.2 kb. Instead of the traditional alkaline lysis method, PFGE was used to detect plasmids.
The cMLS B phenotype has been found to be prevalent among CA-MRSA isolates in Hong Kong and Japan (Otsuka et al., 2007; Ho et al., 2011) . The ermA and ermC genes are usually the main resistant genes responsible. The ermB gene, formerly found in animal strains conferring constitutive resistance to erythromycin and clindamycin, has recently been observed in human isolates in Taiwan and Hong Kong (Lo et al., 2010) . In the current study, the cMLS B phenotype was prevalent in all MLS Bresistant S. aureus isolates and the ermB gene was the most prevalent resistance gene in CA MLS B -resistant S. aureus isolates. Compared with ermA and ermC, the ermB gene is smaller and is usually located on plasmids (Khan & Novick, 1980) . The smaller ermB gene may have a quicker gene transfer among CA S. aureus isolates in Chinese communities. Two strains in the present study showed the fMLS B phenotype and also carried the ermA gene. fMLS B is characterized by its inducible and constitutive expression of ermA (Yoon et al., 2008) . 
Conclusions
The present study demonstrated that CA-MRSA clones isolated from Chinese children exhibited high resistance to non-b-lactams, especially clindamycin, and that the clones had their own resistance characteristics. It also identified ermB as the predominant gene among MLS B -resistant CA S. aureus strains and the mupA gene being located on a different plasmid. Clindamycin should be used carefully in S. aureus infections and rational use of antibiotics should be undertaken to minimize the spread of S. aureus with MDR in China.
